chr11-5698520-G-C
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_006074.5(TRIM22):c.725G>C(p.Arg242Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.543 in 1,612,768 control chromosomes in the GnomAD database, including 244,870 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_006074.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRIM22 | NM_006074.5 | c.725G>C | p.Arg242Thr | missense_variant | 4/8 | ENST00000379965.8 | |
TRIM22 | NM_001199573.2 | c.713G>C | p.Arg238Thr | missense_variant | 4/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRIM22 | ENST00000379965.8 | c.725G>C | p.Arg242Thr | missense_variant | 4/8 | 1 | NM_006074.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.498 AC: 75591AN: 151940Hom.: 19677 Cov.: 32
GnomAD3 exomes AF: 0.500 AC: 124121AN: 248092Hom.: 33067 AF XY: 0.511 AC XY: 68837AN XY: 134594
GnomAD4 exome AF: 0.548 AC: 800183AN: 1460710Hom.: 225185 Cov.: 48 AF XY: 0.549 AC XY: 398720AN XY: 726574
GnomAD4 genome AF: 0.497 AC: 75624AN: 152058Hom.: 19685 Cov.: 32 AF XY: 0.498 AC XY: 37011AN XY: 74316
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 63% of patients studied by a panel of primary immunodeficiencies. Number of patients: 60. Only high quality variants are reported. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at